TJX

TJX Companies

$134.37

-1.18%
Nov 13, 2026
Bobby Quantitative Model
TJX Companies is the world's largest off-price apparel and home fashions retailer, operating more than 5,000 stores across nine countries through four segments — Marmaxx (roughly 61% of sales), HomeGoods (~17%), TJX Canada (~9%), and TJX International (~13%) — selling branded merchandise at meaningful discounts sourced through a flexible, opportunistic buying model. Its scale, 377,000-strong workforce, and deep vendor relationships make it the dominant platform in off-price retail, a structurally advantaged niche where TJX functions as the industry's primary liquidation channel for branded excess inventory rather than a conventional department store. The current investor debate centers on a sharp divergence between operating performance and stock price: TJX posted a strong fiscal Q2 2027 with revenue up 5.4% year over year and raised its full-year outlook, yet the shares fell roughly 15% in August after full-year profit guidance disappointed and two analysts downgraded the name on valuation concerns. The narrative has shifted from 'defensive compounder' to 'how much premium does a 4% comp grower deserve,' particularly as rival Ross Stores posted 10% comparable sales growth and raised guidance, fueling a relative-value debate within off-price retail.

People also watch

Ross Dress for Less

Ross Dress for Less

ROST

Analysis
Burlington

Burlington

BURL

Analysis
Victoria’s Secret

Victoria’s Secret

VSXY

Analysis
Gap Inc.

Gap Inc.

GAP

Analysis
Urban Outfitters

Urban Outfitters

URBN

Analysis

BobbyInvestment Opinion: Should I buy TJX Today?

Rating: Hold with a constructive bias toward accumulating on weakness. The core thesis is that TJX remains the structurally advantaged operator in off-price retail — 18 of 22 analysts rate it Buy with a $171.16 average target implying 26.5% upside from $135.30 — but the current 30.6x trailing PE still embeds premium-compounder expectations that a 5.41% revenue grower has not yet earned, so the risk/reward is balanced rather than compelling at today's price.

The supporting evidence is genuinely strong on profitability and cash: gross margin expanded 268bps YoY to 33.41% in Q2 fiscal 2027 (from 30.73%), operating margin rose to 13.09% from 11.25%, and net income grew to $1.52 billion from $1.24 billion on a 10.01% net margin. Trailing free cash flow of $5.88 billion funds $814 million of quarterly buybacks and $531 million of dividends, ROE is 53.9%, and the forward PE of 23.5x is a 23% discount to the trailing multiple and near the low end of the three-year 19.1x-35.1x band. Against that, the PEG of 2.28x, PS of 2.79x, and PB of 16.5x all sit in the upper portion of historical ranges, and the -16.15% three-month decline with a -15.48 point 12-month relative-strength gap versus SPY shows the market is already repricing the growth premium.

The thesis would upgrade to Buy if TJX delivers a comp re-acceleration toward the 7-8% range (narrowing the gap to Ross Stores' 10%) or if the multiple compresses toward 20x-23x forward while margins hold above 33%, offering a genuine margin of safety. It would downgrade to Sell if comps decelerate below 4%, gross margin rolls back under 31%, or the stock breaks the $122.78 52-week low on volume, confirming a full trend reversal. On balance the stock is fairly valued to modestly overvalued relative to its own history and at a clear premium to off-price peers — the premium is defensible on quality but not on current growth, so patience rather than urgency is warranted.

Sign up to view all

TJX 12-Month Price Forecast

TJX presents a high-quality franchise trading at a still-demanding multiple after a sharp de-rating, which argues for a neutral stance rather than chasing either direction. The margin story is genuinely impressive — gross margin up 268bps YoY and net income up 22% to $1.52 billion — and the 23.5x forward PE is far more digestible than the 30.6x trailing figure, but the 5.41% revenue growth and 2.28x PEG leave little room for error if comps keep slowing. The Street's 26.5% implied upside is unusually wide for a mega-cap defensive and is skewed by high-end outliers, while the $136 low target sitting at the current price signals essentially no downside cushion. I would upgrade to bullish on evidence of comp re-acceleration above 6% or a forward multiple below 21x with margins intact, and downgrade to bearish if gross margin slips below 31% or the $122.78 low breaks.

Historical Price
Current Price $134.37
Average Target $155.50
High Target $198.00
Low Target $122.78

Wall Street consensus

Most Wall Street analysts maintain a constructive view on TJX Companies's 12-month outlook, with a consensus price target around $167.50 and implied upside of +24.7% versus the current price.

Average Target

$167.50

23 analysts

Implied Upside

+24.7%

vs. current price

Analyst Count

23

covering this stock

Price Range

$136 - $190

Analyst target range

Buy
18 (78%)
Hold
5 (22%)
Sell
0 (0%)

Coverage is deep and overwhelmingly constructive: 19 analysts cover TJX with 18 Buy ratings, 4 Hold ratings, and zero Sells, yielding a consensus recommendation of 'buy' and a recommendation mean of 1.55 (where 1.0 is a strong buy). The average target price of $171.16 implies roughly 26.5% upside from the current $135.30, a gap that is unusually wide for a mega-cap defensive name and signals that the Street views the August selloff as an overreaction to a guidance miss rather than a fundamental deterioration. Consensus forward EPS of $6.85 and revenue of $75.50 billion underpin that optimism, and the bullish tilt is reinforced by BofA Securities reiterating its Buy rating as recently as October 27, 2026. However, the sentiment is not uniformly positive — Jefferies downgraded to Hold from Buy on August 26 and Citigroup moved to Neutral from Buy on August 20, both post-earnings, indicating that some analysts see the risk/reward as balanced after the guidance disappointment. The target range of $136.00 to $198.00 is exceptionally wide — a 46% spread from low to high — which signals genuine disagreement about TJX's growth trajectory rather than mere noise. The low target of $136.00 sits essentially at the current price ($135.30), implying the bear case prices in flat-to-negative returns driven by continued comp deceleration, margin pressure from a promotional environment, and multiple compression toward historical norms; the high target of $198.00 (46% above current) assumes a re-acceleration in comps, continued gross margin expansion, and a re-rating back toward the upper end of TJX's historical valuation band. The cluster of August 20 rating actions — UBS, Evercore ISI, Barclays, Morgan Stanley, and BTIG all maintaining Buy/Overweight/Outperform while Gordon Haskett trimmed to Accumulate from Buy and Wells Fargo stayed at Equal Weight — shows the institutional base holding firm but with conviction thinning at the margin. For investors, the wide spread and the recent downgrades argue for treating the consensus target with caution: the average is skewed by high-end outliers, and the fact that the low target equals the current price suggests limited downside protection if the deceleration narrative persists.

Drowning in data?

Find the real signal!

Bulls vs Bears: TJX Investment Factors

The bear case currently has slightly stronger near-term evidence: growth has decelerated to 5.41% YoY, momentum is broken with a -16.15% three-month decline, and the 30.6x trailing PE still sits in the upper third of its historical band despite the selloff. The bull case rests on margin expansion (gross margin up 268bps YoY to 33.41%), a fortress-quality ROE of 53.9%, and a Street consensus that is 18 Buy versus zero Sell with a $171.16 average target implying 26.5% upside. The single most important tension is whether TJX's comp growth can re-accelerate toward Ross Stores' 10% pace or whether mid-single-digit growth is the new normal — if the latter, the premium multiple is unjustified and further de-rating follows; if the former, the August selloff was a generational entry point. The unusually wide $136-$198 target spread (46%) confirms that even professional analysts disagree on this exact question.

Bullish

  • Street consensus firmly Buy despite selloff: 18 of 22 ratings are Buy with zero Sells and a recommendation mean of 1.55, and the $171.16 average target implies 26.5% upside from $135.30. That gap is unusually wide for a mega-cap defensive name, suggesting the Street views the August guidance miss as an overreaction rather than fundamental deterioration.
  • Margins expanding sharply year over year: Q2 fiscal 2027 gross margin rose to 33.41% from 30.73% a year earlier and operating margin climbed to 13.09% from 11.25%, lifting net income to $1.52 billion from $1.24 billion. Gross margin has now climbed sequentially from 30.86% in Q4 2026 to 31.28% in Q1 to 33.41% in Q2, showing durable merchandise-margin and freight tailwinds.
  • Valuation reset to a more digestible level: After a 16.15% three-month decline, the forward PE of 23.5x sits well below the 30.6x trailing multiple and near the low end of TJX's three-year 19.1x-35.1x band. The 23% trailing-to-forward compression means investors are paying far less for next year's consensus EPS of $6.85 than for depressed trailing earnings.
  • Defensive low-beta profile with strong cash generation: A beta of 0.587 makes TJX roughly 41% less volatile than the market, and trailing free cash flow of $5.88 billion supports $814 million of quarterly buybacks and $531 million of dividends. ROE of 53.9% and ROA of 13.5% remain exceptional for apparel retail.

Bearish

  • Growth decelerating versus Ross Stores: Revenue growth slowed from 9.2% YoY in Q1 fiscal 2027 to 5.41% in Q2, while Ross Stores posted 10% comparable sales growth and raised guidance at similar valuations. That relative-value gap is the central fundamental vulnerability in the off-price debate.
  • Valuation still prices in premium-compounder status: The trailing PE of 30.6x sits in the upper third of its three-year 19.1x-35.1x range, above the 23.7x at fiscal Q4 2026, while PS of 2.79x and PB of 16.5x are near the top of historical bands. A de-rating to the 23x-25x midpoint would imply roughly 15-20% further downside absent an earnings recovery.
  • PEG of 2.28x flags expensive growth: A PEG ratio of 2.28x signals the stock is expensive relative to its mid-single-digit growth rate, reinforcing the concern that drove the August selloff. The forward multiple of 23.5x requires roughly 30% EPS growth embedded in the trailing-to-forward spread, a tall order for a 4-5% comp grower.
  • Momentum broken and underperforming badly: TJX is down 16.15% over three months, 12.30% YTD, and 5.89% over one year versus SPY's +9.59%, a -15.48 point 12-month relative-strength gap. At $135.30 the stock sits just 21.5% above its 52-week low of $122.78 and 20.4% below its high, in the lower quartile of its range.

TJX Technical Analysis

TJX is in a clear intermediate downtrend despite a modest longer-term base, with the stock down 5.89% over the past year and 12.30% year to date, badly lagging the S&P 500's +9.59% one-year and +7.83% YTD returns — a relative-strength gap of -15.48 percentage points over 12 months and -20.13 points YTD. At $135.30, the stock sits just 21.5% above its 52-week low of $122.78 and 20.4% below its 52-week high of $170.00, placing it in the lower quartile of its 52-week range (approximately 26% of the range from the low). That positioning signals a broken momentum profile rather than a healthy pullback: the stock has surrendered nearly all of its 2026 gains and is testing territory last seen before the May breakout, making it a 'show-me' setup rather than a falling knife only because the 52-week low has held so far. Recent momentum is decisively negative and accelerating to the downside: the stock is down 16.15% over three months and 2.52% over the past month, with the 3-month decline far outpacing the 1-year decline, indicating the selling pressure is recent and intensifying rather than a slow bleed. Notably, the 1-month relative strength versus SPY is actually positive at +2.47 points (TJX -2.52% vs. SPY -4.99%), suggesting the stock is beginning to outperform a weakening tape — a potential early stabilization signal — though the -11.24 point 3-month relative strength confirms the damage done since the August guidance disappointment. The most recent session saw a -2.37% drop to $135.30 on volume of roughly 7.16 million shares, showing sellers remain in control near-term and that rallies (such as the November 4 bounce to $144.76) are being sold. Key technical levels are well defined: support sits at the 52-week low of $122.78, roughly 9.3% below the current price, and a breakdown there would confirm a full trend reversal and likely trigger momentum-driven selling; resistance lies at the $170.00 52-week high, 25.6% above current levels, with intermediate resistance around the $147-$150 zone where the stock repeatedly failed in October. A beta of just 0.587 means TJX is roughly 41% less volatile than the market, which is favorable for position sizing and downside protection in a risk-off tape but also implies the stock will lag in sharp rallies; the max drawdown of -27.06% shows that even low-beta defensives can experience meaningful peak-to-trough pain when valuation compresses.

Beta

0.59

0.59x market volatility

Max Drawdown

-27.1%

Largest decline past year

52-Week Range

$123-$170

Price range past year

Annual Return

-8.2%

Cumulative gain past year

PeriodTJX ReturnS&P 500
1m-5.9%-2.3%
3m-11.7%-2.8%
6m-8.9%+2.1%
1y-8.2%+12.3%
ytd-12.9%+10.6%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

TJX Fundamental Analysis

TJX's revenue trajectory remains solidly positive but is decelerating relative to expectations: fiscal Q2 2027 revenue came in at $15.18 billion, up 5.41% year over year from $14.40 billion, following Q1 revenue of $14.32 billion (up 9.2% YoY from $13.11 billion) and Q4 2026 revenue of $17.74 billion (up 8.5% YoY from $16.35 billion). The sequential growth rates tell the story — YoY growth has slowed from roughly 9% in Q1 to 5.4% in Q2 — which is precisely why the stock sold off despite the headline beat, and the segment mix shows Marmaxx at $9.11 billion and HomeGoods at $2.51 billion doing the heavy lifting while TJX Canada ($1.47 billion) and TJX International ($2.09 billion) contribute smaller, more FX-sensitive growth. Consensus estimates project full-year revenue of approximately $75.50 billion, implying continued mid-single-digit growth, but the deceleration narrative versus Ross Stores' 10% comp growth is the central fundamental debate and the key risk to the investment case. Profitability is robust and improving: Q2 2027 net income reached $1.52 billion with a net margin of 10.01%, up from $1.24 billion and an 8.63% margin in the year-ago quarter, while gross margin expanded to 33.41% from 30.73% a year earlier and operating margin rose to 13.09% from 11.25%. The multi-quarter margin trend is clearly upward — gross margin has climbed from 30.86% in Q4 2026 to 31.28% in Q1 2027 to 33.41% in Q2 2027 — reflecting strong merchandise margins, lower freight costs, and disciplined expense control, with SG&A of $3.09 billion held to just 20.3% of revenue. A trailing net margin of 9.10% and operating margin of 11.89% are healthy for apparel retail and demonstrate the off-price model's structural cost advantage, though the market's concern is whether margin expansion can continue to offset slowing top-line growth. The balance sheet and cash generation are solid but not fortress-like: trailing free cash flow is $5.88 billion, Q2 operating cash flow was $2.23 billion against capex of $497 million (FCF of $1.73 billion), and the company returned capital aggressively with $814 million in buybacks and $531 million in dividends in the quarter. Debt-to-equity of 1.32 reflects a leveraged but manageable capital structure (interest coverage is very high given minimal interest expense), the current ratio of 1.14 is adequate though not generous, and ROE of 53.9% and ROA of 13.5% are exceptional — though the ROE is flattered by a high equity multiplier of roughly 3.5x. Cash of $6.00 billion provides ample liquidity, and the $5.88 billion TTM FCF against a $168.5 billion market cap implies an FCF yield of roughly 3.5%, which is modest for a retailer but consistent with TJX's premium-quality, low-beta profile.

Quarterly Revenue

$15.2B

2026-08

Revenue YoY Growth

+5.4%

YoY Comparison

Gross Margin

33.4%

Latest Quarter

Free Cash Flow

$5.9B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

HomeGoods
Marmaxx
TJX Canada
TJX International

Open an Account, get $2 TSLA now!

Valuation Analysis: Is TJX Overvalued?

Because TJX is solidly profitable (Q2 2027 net income of $1.52 billion), the PE ratio is the appropriate primary metric, and the stock trades at a trailing PE of 30.6x versus a forward PE of 23.5x — a 23% compression that implies the market expects meaningful EPS growth (consensus forward EPS of $6.85 versus a trailing figure depressed by the current-quarter optics). The gap between trailing and forward multiples is the crux of the valuation debate: investors are paying 30.6x for current earnings but only 23.5x for next year's, which is reasonable only if TJX can deliver the roughly 30% earnings growth embedded in that spread — a tall order for a mid-single-digit revenue grower, meaning the forward multiple is doing a lot of heavy lifting. On a PEG basis of 2.28x, the stock looks expensive relative to its growth rate, reinforcing the concern that drove the August selloff. Against apparel retail peers, TJX commands a clear premium: its PS ratio of 2.79x and EV/Sales of 2.52x sit above typical off-price and department store multiples, while its EV/EBITDA of 20.6x and PB of 16.5x reflect the market's willingness to pay up for the sector's best operator. The premium is partially justified by TJX's superior ROE (53.9%), net margin (9.10%), and consistent FCF generation, but the spread versus Ross Stores — which is growing comps at more than double TJX's rate at similar valuations — is the key relative-value vulnerability, and the 30.6x trailing PE versus a historical norm in the low-to-mid 20s suggests the market has been pricing in optimistic expectations. Historical context is instructive: TJX's PE ratio has ranged from roughly 19.1x (Q4 2024) to 35.1x (Q1 2025) over the past three years, and the current 30.6x sits in the upper third of that band — well above the 23.7x recorded at fiscal Q4 2026 and the 25.4x at fiscal Q4 2025. Similarly, the PS ratio of 2.79x is near the high end of its historical 2.5x-3.0x range, and the PB of 16.5x is at the top of a 14x-17x band. This positioning means the market is still pricing TJX as a premium compounder even after a 16% three-month decline — a de-rating toward the 23x-25x historical midpoint would imply further downside of roughly 15-20% absent an earnings recovery, making valuation the single biggest risk to the stock at current levels.

PE

30.6x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 19x~35x

vs. Industry Avg

20.5x

Industry PE ~20.5x*

EV/EBITDA

20.6x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks center on decelerating growth and a leveraged balance sheet. Revenue growth slowed from 9.2% YoY in Q1 fiscal 2027 to 5.41% in Q2, and consensus full-year revenue of $75.50 billion implies continued mid-single-digit expansion that may not justify the current multiple. Debt-to-equity of 1.32 and a current ratio of just 1.14 leave limited cushion, while the 53.9% ROE is flattered by an equity multiplier of roughly 3.5x, meaning the headline profitability overstates underlying balance-sheet strength. The 30.6x trailing PE versus a forward PE of 23.5x embeds roughly 30% EPS growth that a 4-5% comp grower will struggle to deliver, making earnings volatility a live risk if margins stop expanding.

Market and competitive risks are dominated by valuation compression and the Ross Stores relative-value gap. TJX trades at a PS of 2.79x and EV/EBITDA of 20.6x, a premium to off-price and department-store peers that is only justified if TJX remains the sector's best operator; Ross growing comps at more than double TJX's rate at similar valuations is the key vulnerability. The August guidance disappointment triggered a 15% single-month decline and two downgrades (Jefferies to Hold, Citigroup to Neutral), showing how quickly sentiment can shift for a premium-multiple retailer. A beta of 0.587 provides some macro insulation, but the Fed's stated "no tolerance" for inflation and risk of further rate hikes could compress multiples across consumer discretionary regardless of TJX's defensive characteristics.

The worst-case scenario is a continuation of comp deceleration combined with multiple compression toward historical norms. If TJX's comps stall near 4% while Ross sustains double-digit growth, the market could re-rate TJX toward the 23x-25x historical PE midpoint, implying roughly 15-20% downside from $135.30, or toward the 52-week low of $122.78, a 9.3% decline. A breakdown below that $122.78 support would confirm a full trend reversal and likely trigger momentum-driven selling, and the stock's -27.06% max drawdown shows that even low-beta defensives can suffer meaningful peak-to-trough pain. In a severe adverse scenario combining a comp miss with a broad consumer-discretionary de-rating, an investor could lose 20-30% from current levels, with the analyst low target of $136.00 offering essentially no downside cushion.

FAQ

Ranked by severity: first, valuation compression — the 30.6x trailing PE in the upper third of its 19.1x-35.1x three-year band could de-rate toward the 23x-25x midpoint, implying 15-20% downside. Second, growth deceleration — revenue growth slowed from 9.2% YoY in Q1 to 5.41% in Q2 while Ross Stores posted 10% comps at similar valuations, the central relative-value vulnerability. Third, margin reversal — the 268bps YoY gross margin expansion to 33.41% is the one pillar offsetting slower revenue, and a rollback under 31% in a promotional environment would undermine the thesis. Fourth, macro and rate sensitivity — Fed Chair Warsh's 'no tolerance' inflation stance raises the risk of further rate hikes that could compress consumer-discretionary multiples broadly, even with TJX's defensive 0.587 beta. Company-specific execution risk is moderate given the 1.32 debt-to-equity and 1.14 current ratio, but the 53.9% ROE is flattered by roughly 3.5x equity multiplier.

The 12-month forecast is split into three scenarios: a 55% base case of $140-$171 in which revenue grows 4-6% to the $75.50 billion consensus, gross margin holds in the low-33% range, and the forward multiple stabilizes at 21x-24x; a 20% bull case of $171-$198 driven by comps re-accelerating to 7-8%, gross margin above 33%, and a re-rating toward the upper historical band; and a 25% bear case of $122.78-$136 if comps decelerate toward 3-4%, gross margin rolls back under 31%, and the multiple compresses toward the 23x-25x midpoint. The base case is most likely, and its key assumption is that the August guidance disappointment is digested without a full re-rating — the stock recovers modestly from oversold levels but stays in the mid-20s forward multiple. The wide $136-$198 analyst target spread (46%) confirms genuine disagreement about whether mid-single-digit growth is the new normal.

TJX is fairly valued to modestly overvalued on its own history and at a clear premium to off-price peers. The trailing PE of 30.6x sits in the upper third of its three-year 19.1x-35.1x band and well above the 23.7x recorded at fiscal Q4 2026, while PS of 2.79x and PB of 16.5x are near the top of their historical ranges. The forward PE of 23.5x is far more digestible — a 23% compression from trailing — but that discount requires roughly 30% EPS growth to the $6.85 consensus, a tall order for a 5.41% revenue grower, and the 2.28x PEG ratio flags the stock as expensive relative to its growth rate. The market is still paying a premium-compounder multiple for a mid-single-digit grower, which is why the August guidance miss triggered a 15% single-month decline. A de-rating toward the 23x-25x historical midpoint would imply roughly 15-20% downside absent an earnings recovery, so valuation is the single biggest risk at current levels.

From a risk/reward perspective TJX is balanced rather than compelling at $135.30: the $171.16 average analyst target implies 26.5% upside with 18 Buy ratings versus zero Sells, but the $136.00 low target sits essentially at the current price, meaning the bear case prices in flat returns. The downside is real — a de-rating toward the 23x-25x historical PE midpoint implies roughly 15-20% further downside, and a break of the $122.78 52-week low would be about 9.3% below current levels. The upside depends on comps re-accelerating toward 6-8% and closing the gap to Ross Stores' 10% growth, which is not yet evidenced given the deceleration from 9.2% YoY in Q1 to 5.41% in Q2. It is a reasonable buy for patient, lower-volatility-oriented investors accumulating on weakness with a 12-24 month horizon, and a poor buy for anyone chasing near-term momentum given the -16.15% three-month decline and -15.48 point 12-month relative-strength gap versus SPY.

TJX is better suited to long-term holding than short-term trading. Its 0.587 beta makes it roughly 41% less volatile than the market, which is favorable for position sizing but means it will lag in sharp rallies and offers limited short-term trading edge; the -16.15% three-month decline and -2.37% single-session drop to $135.30 show sellers still control near-term price action. The 1.09% dividend yield with a conservative 33.5% payout ratio, $5.88 billion trailing free cash flow, and $814 million quarterly buybacks support a compounding-holder profile rather than a momentum trade. Earnings visibility is reasonable given the off-price model's structural advantages and 53.9% ROE, but the 30.6x trailing multiple means multiple compression risk dominates the near term. A suggested minimum holding period of 12-24 months allows time for comp re-acceleration or margin durability to be proven and for the valuation to normalize, with the $122.78 52-week low as the key risk level to monitor.